| SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition A Nelde, T Bilich, JS Heitmann, Y Maringer, HR Salih, M Roerden, ... Nature immunology 22 (1), 74-85, 2021 | 588 | 2021 |
| Interleukin 23 expression in pyoderma gangrenosum and targeted therapy with ustekinumab E Guenova, A Teske, B Fehrenbacher, S Hoerber, A Adamczyk, ... Archives of dermatology 147 (10), 1203-1205, 2011 | 201 | 2011 |
| A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity JS Heitmann, T Bilich, C Tandler, A Nelde, Y Maringer, M Marconato, ... Nature 601 (7894), 617-622, 2022 | 178 | 2022 |
| T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals T Bilich, A Nelde, JS Heitmann, Y Maringer, M Roerden, J Bauer, J Rieth, ... Science translational medicine 13 (590), eabf7517, 2021 | 153 | 2021 |
| IκBζ is a transcriptional key regulator of CCL2/MCP-1 DG Hildebrand, E Alexander, S Hörber, S Lehle, K Obermayer, NA Münck, ... The Journal of Immunology 190 (9), 4812-4820, 2013 | 97 | 2013 |
| Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity M Becker, M Strengert, D Junker, PD Kaiser, T Kerrinnes, B Traenkle, ... Nature communications 12 (1), 1152, 2021 | 69 | 2021 |
| Robust and durable serological response following pediatric SARS-CoV-2 infection H Renk, A Dulovic, A Seidel, M Becker, D Fabricius, M Zernickel, D Junker, ... Nature Communications 13 (1), 128, 2022 | 59 | 2022 |
| Harmonization of immunoassays for biomarkers in diabetes mellitus S Hörber, P Achenbach, E Schleicher, A Peter Biotechnology advances 39, 107359, 2020 | 52 | 2020 |
| The atypical inhibitor of NF-κB, IκBζ, controls macrophage interleukin-10 expression S Hörber, DG Hildebrand, WS Lieb, S Lorscheid, S Hailfinger, ... Journal of Biological Chemistry 291 (24), 12851-12861, 2016 | 51 | 2016 |
| Durable spike-specific T cell responses after different COVID-19 vaccination regimens are not further enhanced by booster vaccination Y Maringer, A Nelde, SM Schroeder, J Schuhmacher, S Hörber, A Peter, ... Science immunology 7 (78), eadd3899, 2022 | 45 | 2022 |
| Evaluation of three fully-automated SARS-CoV-2 antibody assays S Hörber, J Soldo, L Relker, S Jürgens, J Guther, S Peter, R Lehmann, ... Clinical Chemistry and Laboratory Medicine (CCLM) 58 (12), 2113-2120, 2020 | 45 | 2020 |
| Severe SARS-CoV-2 infection inhibits fibrinolysis leading to changes in viscoelastic properties of blood clot: a descriptive study of fibrinolysis in COVID-19 S Hammer, H Häberle, C Schlensak, M Bitzer, NP Malek, ... Thrombosis and haemostasis 121 (11), 1417-1426, 2021 | 39 | 2021 |
| Preexisting and post–COVID-19 immune responses to SARS-CoV-2 in patients with cancer T Bilich, M Roerden, Y Maringer, A Nelde, JS Heitmann, ML Dubbelaar, ... Cancer discovery 11 (8), 1982-1995, 2021 | 38 | 2021 |
| Comparison of three different serum-free light-chain assays—implications on diagnostic and therapeutic monitoring of multiple myeloma A Schieferdecker, S Hörber, M Ums, B Besemer, C Bokemeyer, A Peter, ... Blood cancer journal 10 (1), 2, 2020 | 31 | 2020 |
| Evaluation of the first immunosuppressive drug assay available on a fully automated LC-MS/MS-based clinical analyzer suggests a new era in laboratory medicine S Hörber, A Peter, R Lehmann, M Hoene Clinical Chemistry and Laboratory Medicine (CCLM) 59 (5), 913-920, 2021 | 26 | 2021 |
| Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants including edoxaban F Härtig, I Birschmann, A Peter, S Hörber, M Ebner, M Sonnleitner, ... Neurological Research and Practice 3, 1-9, 2021 | 20 | 2021 |
| Hemostatic alterations linked to body fat distribution, fatty liver, and insulin resistance S Hörber, R Lehmann, N Stefan, J Machann, AL Birkenfeld, R Wagner, ... Molecular Metabolism 53, 101262, 2021 | 16 | 2021 |
| Typically asymptomatic but with robust antibody formation: Children’s unique humoral immune response to SARS-CoV-2 H Renk, A Dulovic, M Becker, D Fabricius, M Zernickel, D Junker, A Seidel, ... medRxiv, 2021.07. 20.21260863, 2021 | 16 | 2021 |
| Diagnostic accuracy of a novel chromogenic direct thrombin inhibitor assay: clinical experiences for dabigatran monitoring S Poli, F Haertig, C Spencer, M Ebner, I Birschmann, J Kuhn, S Faix, ... Thrombosis and Haemostasis 117 (12), 2369-2375, 2017 | 16 | 2017 |
| Lifestyle intervention improves prothrombotic coagulation profile in individuals at high risk for type 2 diabetes S Hörber, R Lehmann, L Fritsche, J Machann, AL Birkenfeld, HU Häring, ... The Journal of Clinical Endocrinology & Metabolism 106 (8), e3198-e3207, 2021 | 13 | 2021 |
